Jpn J Cancer Res 1994, 85: 645–651.PubMed 63. Nogawa T, Kamano Y, Yamashita A, Pettit GR: Isolation and Structure of Five New Cancer Cell Growth Inhibitory Bufadienolides from the Chinese Traditional Drug Ch’an Su. J Nat prod 2001,

64: AZD1390 in vivo 1148–1152.CrossRefPubMed 64. Huh JE, Kang KS, Ahn KS, Kim DH, Saiki I, Kim SH: Mylabris phalerlata induces apoptosis by caspase activation following cytochrome c release and Bid cleavage. Life Sci 2003, 73: 2249–2262.CrossRefPubMed 65. Wang CC, Chen LG, Yang LL: Cytotoxic activity of sesquiterpenoids from Atractylodes ovata on leukemia cell lines. Planta Med 2002, 68: 204–208.CrossRefPubMed 66. Ahn BZ, Yoon YD, Lee YH, Kim BH, Sok DE: Inhibitory effect of bupleuri radix saponins on adhesion of some solid tumor cells and relation to hemolytic action: screening of 232 herbal drugs for anti-cell adhesion. Planta Med 1998, 64: 220–224.CrossRefPubMed 67. Antony S, Kuttan R, Kuttan G: Immunomodulatory activity of curcumin. learn more Immunol Invest 1999, 28: 291–303.CrossRefPubMed

68. Xiang De-bing XJ, Wang D, Wang G, Zhong WZ, Li ZP: Clinical study of De lisheng injection combined with transcatheter arterial chemoembolization in treatment of primary hepatocellular carcinoma. Modern Oncology 2006, 14 (7) : 861–862. 69. Zhang CJ, Liang TJ, Yu MB: Clinical study of combination therapy of Jinlong capsule and chemical therapy and embolization by hepatic BMN 673 in vitro artery catheterization on primary hepatic carcinoma. Beijing Medical Journal 2005, 27 (6) : 357–359. 70. Cao LW, Wang XC, Zhang FL, Ning HF, Sun YQ, Yan LF: Clinical Observation of Ganfukang capsule combined with TACE in primary liver cancer treatment. Shandong Medical Journal 2005, 45 (2) : 13–14. 71. Wu T, Li Y, Bian Z, Liu G, Moher D: Randomized trials published in some Chinese journals: how many are randomized? Trials 2009, 10: 46.CrossRefPubMed 72. Shu X, McCulloch M, Xiao

H, Broffman M, Gao J: Chinese herbal medicine and chemotherapy in the PAK5 treatment of hepatocellular carcinoma: a meta-analysis of randomized controlled trials. Integrative cancer therapies 2005, 4: 219–229.CrossRefPubMed 73. McCulloch M, See C, Shu XJ, Broffman M, Kramer A, Fan WY, Gao J, Lieb W, Shieh K, Colford JM Jr: Astragalus-based Chinese herbs and platinum-based chemotherapy for advanced non-small-cell lung cancer: meta-analysis of randomized trials. J Clin Oncol 2006, 24: 419–430.CrossRefPubMed 74. McCulloch M, Broffman M, Gao J, Colford JM Jr: Chinese herbal medicine and interferon in the treatment of chronic hepatitis B: a meta-analysis of randomized, controlled trials. American journal of public health 2002, 92: 1619–1628.CrossRefPubMed 75. Cho WC, Chen HY: Transcatheter arterial chemoembolization combined with or without Chinese herbal therapy for hepatocellular carcinoma: meta-analysis. Expert opinion on investigational drugs 2009, 18: 617–635.CrossRefPubMed 76.